Piper Sandler Initiates Coverage On Bioage Labs with Overweight Rating, Announces Price Target of $73
Benzinga Newsdesk 9 months ago
NewsPrice TargetInitiationAnalyst Ratings
Piper Sandler analyst Yasmeen Rahimi initiates coverage on Bioage Labs (NASDAQ:BIOA) with a Overweight rating and announces Price Target of $73.
Piper Sandler analyst Yasmeen Rahimi initiates coverage on Bioage Labs (NASDAQ:BIOA) with a Overweight rating and announces Price Target of $73.